Esophageal stent HANAROSTENT®TTS (CCC)

INDICATIONS Palliative treatment for patient with unresectable esophageal or upper gastro-intestinal neoplasm. Pre-operative patient for dysphagia and malnutrition during tumor reduction treatment (such as cytostatic agent and/or irradiation therapy) prior to planned surgery. Patient suffering from trcheo-esophageal fistuala FEATURES For tight anatomy Fluoroscopic stent position and monitoring Repositioning lasso on the proximal